Member Info for Laura2022

Is WG worth a gamble at 20-22p .?

Glad I took my profits many weeks ago above 30-35p

Sorry to see

Goup

With green filter box i assume its avocet ?

Another serial troll

Can buy and sell at 0.4p which is strange

TS

He's an old ID re incarnation

Look at his last3 weeks since joining LSE

Report to info@lse.co.uk then filter

In auction at 0.4p for last 8 mins

Yes Goupplease

Undervalued

Strip away the cash of placing + end of calender year (c£700,000 in total) leaves just £500k enterprise value

Honestly ridiculous given the A.I dosing too potential ( see KingHomer posts at the weekend)

Following the £100k contract 2 weeks ago , More to come as shown in presentation

Osd

Sushi is well known for constant ramping ,lies and U turns

His posts last 18mths are hilarious on CPX EME WG etc

And now going to US and leaving AIM

Osd

I filtered him 3mths ago

Look at his posting history, he trots out the same nonsense while ramping EME and WG( claimed 80p target there..they had low ball 35p offer yesterday)

He's simply a nuisance

That's now 2 out of the 9 near term contracts now announced since Marcn presentation

Quick re cap

Strip away the cash of placing + end of calender year (c£700,000 in total) leaves just £500k enterprise value

Honestly ridiculous given the A.I dosing too potential ( see KingHomer posts at the weekend)

Following the £100k contract 2 weeks ago , More to come as shown in presentation

91 "warm leads" which means discussions taken place

16 active - ( specifc contract focus)

9 at proposal stage (announced shortly)....some with Tier 1 companies

Expecting "very strong " H2 and beyond to 2026

Full year revs if hit will be 30% increase on 2024

Physiomics Awarded New Contract by Numab Therapeutics

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a new contract with its long-standing client, Numab Therapeutics AG.

The project will involve the application of modelling and simulation techniques to inform pre-clinical development of a multi-specific antibody designed to activate anti-tumor immune responses for the treatment of cancer. This project is expected to complete within the next two months.

This latest collaboration extends the history of the Company working with Numab Therapeutics in applying Model Informed Drug Development to address complex challenges with mathematical modelling and simulation techniques.

Thanks Corry

Trench

It may have not gone unnoticed that since the Trump debacle allot of low volume onAIM ha followed

As you only post on PYCi don't know how much you follow the wider market?

Also strange his the rather obtuse poster Debull has seemingly deleted his account as has 12mth troll Jaari888

I do often wonder if there are wider agendas

I have not seen yourself or anyone else mention it last 12mths

Unless you csn show me otherwise

MCAM

Strange 1st post on ANR/REE in 4yrs?

You would think main market would be MORE volume ?

What a bitter person pete is

And rather untrustworthy

Suggestions are that something is underfoot. Be it good or bad - time will tell

?? Trench "suggestions "?

Afternoon Trench

Wonder if we'll get a role going forward with Kier Starmer £600mlm innovation pledge

Will bode well for other drug discovery oncology stocks like PYC etc